Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 4
2(40.0%)
5Total
N/A(3)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02327962Completed

Comparing an Automatic PWV Analyser to Pulse Pressure in Hemodialysis

Role: lead

NCT01898234Not ApplicableCompleted

Dialysis Membranes and Hemodynamic Tolerance

Role: lead

NCT01666301Not ApplicableCompleted

ESAs, Reticulocyte Dynamic and Hemoglobin Variability

Role: lead

NCT00600639Phase 4Terminated

Non-Invasive Mechanical Ventilation in Elderly Patients

Role: collaborator

NCT01224314Not ApplicableCompleted

Potassium in Haemodialysis Fluids and Haemodynamics

Role: lead

NCT00718289Phase 4Completed

Citrate- Versus Acetate-Based Dialysate in Bicarbonate Haemodialysis: Consequences on Haemodynamics, Coagulation, Acid-Base Status and Electrolytes

Role: lead

All 6 trials loaded